A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

BioChaperone insulin lispro

BioChaperone insulin lispro bolus infusion followed by test meal intake

DRUG

Humalog®

Humalog® bolus infusion followed by test meal intake

Trial Locations (1)

Profil GmbH, Neuss